Mineralization of bone-related SaOS-2 cells under physiological hypoxic conditions

FEBS J. 2016 Jan;283(1):74-87. doi: 10.1111/febs.13552. Epub 2015 Nov 5.

Abstract

Inorganic polyphosphate (polyP) is a physiological energy-rich polymer with multiple phosphoric anhydride bonds. In cells such as bone-forming osteoblasts, glycolysis is the main pathway generating metabolic energy in the form of ATP. In the present study, we show that, under hypoxic culture conditions, the growth/viability of osteoblast-like SaOS-2 cells is not impaired. The addition of polyP to those cells, administered as amorphous calcium polyP nanoparticles (aCa-polyP-NP; approximate size 100 nm), significantly increased the proliferation of the cells. In the presence of polyP, the cells produce significant levels of lactate, the end product of anaerobic glycolysis. Under those conditions, an eight-fold increase in the steady-state level of the membrane-associated carbonic anhydrase IX is found, as well as a six-fold induction of the hypoxia-inducible factor 1. Consequently, biomineral formation onto the SaOS-2 cells decreases under low oxygen tension. If the polyP nanoparticles are added to the cells, the degree of mineralization is enhanced. These changes had been measured also in human mesenchymal stem cells. The assumption that the bicarbonate, generated by the carbonic anhydrase in the presence of polyP under low oxygen, is deposited as a constituent of the bioseeds formed during initial hydroxyapatite formation is corroborated by the identification of carbon besides of calcium, oxygen and phosphorus in the initial biomineral deposit onto the cells using the sensitive technology of high-resolution energy dispersive spectrometry mapping. Based on these data, we conclude that polyP is required for the supply of metabolic energy during bone mineral formation under physiological, hypoxic conditions, acting as a 'metabolic fuel' for the cells to grow.

Keywords: bone; carbonic anhydrase; hypoxic conditions; mineralization; polyphosphate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Neoplasm / metabolism
  • Calcification, Physiologic / drug effects
  • Calcification, Physiologic / physiology*
  • Calcium Phosphates / chemistry
  • Calcium Phosphates / metabolism
  • Calcium Phosphates / pharmacology
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases / metabolism
  • Cell Hypoxia / drug effects
  • Cell Hypoxia / physiology
  • Cell Line
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Humans
  • Lactic Acid / metabolism
  • Nanoparticles / chemistry
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Oxygen / metabolism
  • Oxygen / pharmacology*
  • Particle Size
  • Structure-Activity Relationship
  • Surface Properties

Substances

  • Antigens, Neoplasm
  • Calcium Phosphates
  • amorphous calcium phosphate
  • Lactic Acid
  • CA9 protein, human
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases
  • Oxygen